This study looks at how safe and effective a new medicine called ION775 is for people with high triglycerides (a type of fat in the blood). The study lasts for about one year, including 6 months of taking the medicine and 6 months of follow-up.
Hypertriglyceridemia (HTG) is when triglyceride levels are ≥ 350 mg/dL, and severe hypertriglyceridemia (sHTG) means levels are ≥ 500 mg/dL. Participants must be adults and already taking medications to lower their lipid levels. Some cannot join if they have certain health conditions like high blood sugar (HbA1c ≥ 8.5%) or liver/kidney problems.
- Study length: 4-6 weeks preparation, 6 months treatment, 6 months follow-up.
- Participants must already be taking medication for lipid management.
- Certain health conditions may prevent joining the study, such as high blood sugar or kidney issues.
How understandable was the trial content above?
Hard to understand
Easy to understand